ReviewPharmaceutics2024
Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy.
Stefania Douka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewPharmaceutics2024
Stefania Douka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.